Literature DB >> 6294677

Attenuation of pentobarbital-elicited hypothermia in rats with a history of pentobarbital-LiCl pairings.

H K Taukulis.   

Abstract

Rats were given five separate pairings (sequential IP injections) of pentobarbital and lithium chloride, both hypothermia-inducing agents. When the animals were subsequently tested with a single injection of pentobarbital alone, they exhibited an attenuated hypothermia relative to controls that had either (a) received pentobarbital-LiCl pairings spaced twenty-four hours apart, or (b) received only placebo injections of normal saline. This phenomenon provides further evidence that rats can learn an association between drug states and may help to explain why pentobarbital-LiCl pairings tend to eliminate pentobarbital's capacity to produce a conditioned flavor aversion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294677     DOI: 10.1016/0091-3057(82)90348-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

Review 1.  The role of US signal value in contingency, drug conditioning, and learned helplessness.

Authors:  M J Goddard
Journal:  Psychon Bull Rev       Date:  1999-09

2.  Conditional hyperthermia in response to atropine associated with a hypothermic drug.

Authors:  H K Taukulis
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Role of hypothermia in ethanol-induced conditioned taste aversion.

Authors:  C L Cunningham; D M Hawks; D R Niehus
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Conditioned slowing of stomach emptying produced by Pavlovian pairings of a drug CS or a place with lithium chloride.

Authors:  B T Lett
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Morphine as a conditioned stimulus in a conditioned emotional response paradigm.

Authors:  N M Bormann; D A Overton
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.